This is possible because these medications act through different mechanisms
Report the issue to the supplier if possible, as this helps protect others
While AOD-9604 does not stimulate cell proliferation (no IGF-1 elevation), the precautionary principle applies for active malignancies
Safety Profile Across Patient Populations and Risk Factors Safety outcomes vary based on individual factors: baseline B12 status, kidney function, history of injection reactions, and concurrent medications
Because NAD+ Injections with NMN and 5-Amino-1MQ influence cellular metabolism, they should always be administered under the guidance of a qualified healthcare professional
AOD 9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (GH fragment 176191), structurally modified with an N-terminal tyrosine residue to enhance stability in experimental systems